Explore our core clinical, nutritional, and formulation-grade hydrolyzed proteins engineered for optimal absorption and therapeutic bioactivity.
Dietary interventions utilizing optimized protein structures represent a cornerstone in modern clinical nutrition, therapeutic recovery, and metabolic health management. Hydrolyzed proteins—macromolecules systematically cleaved via targeted enzymatic hydrolysis into short-chain peptides and free amino acids—bypass traditional digestion pathways to deliver rapid nitrogen absorption. By dramatically minimizing allergenicity and optimizing systemic bioavailability, hydrolyzed protein solutions address critical physiological demands that intact proteins cannot meet.
As a global pioneer in bioactive peptide biotechnology, Hangzhou Fderla Biology Co., Ltd. integrates state-of-the-art enzymatic shearing platforms with stringent clinical metrics. Our primary objective is to supply global enterprise buyers, clinical supplement manufacturers, and healthcare brand owners with standardized bioactive proteins that facilitate metabolic homeostasis and targeted tissue recovery.
The biological efficacy of a hydrolyzed protein is fundamentally dictated by its molecular weight distribution (measured in Daltons, Da). In intact proteins, complex tertiary folding delays digestion and absorption. Through our controlled enzymatic processes, we consistently achieve a molecular weight profile where over 85% of peptides fall below 1,000 Daltons. These low-molecular-weight tripeptides and dipeptides utilize the PepT1 transporter system in the human intestinal brush border membrane. This pathway ensures a faster, energy-efficient absorption rate compared to free amino acids, avoiding competition for individual amino acid transport sites.
Exploring the technology pipeline that drives bioactivity optimization and the future of tailored clinical nutrition.
By leveraging machine learning algorithms, we predict precise enzyme-to-substrate interactions. This allows us to target specific peptide sequences to unlock biological pathways associated with cardiovascular, joint, and gut health, eliminating trial-and-error R&D.
Our production facilities implement advanced multi-stage ultrafiltration and nanofiltration membranes. This enables us to isolate and concentrate highly specific molecular weight fractions while completely removing any unhydrolyzed fractions or mineral salts.
Traditional hydrolysates suffer from bitter taste profiles due to hydrophobic amino acids. Our proprietary processing technology shields bitter-tasting hydrophobic terminals, creating clean-tasting bases suited for unflavored applications.
The future of nutritional intervention lies in customized proteomics. Instead of relying on general protein intake, tomorrow's healthcare models will prescribe distinct amino acid and peptide arrays designed to target individual metabolic deficits. Hangzhou Fderla Biology is at the forefront of this shift, researching specific peptide sequences that act as signaling molecules to activate GLP-1 pathways, support gut lining repair, and regulate systemic inflammation.
The global demand for hydrolyzed proteins is undergoing structural growth. Historically restricted to niche clinical settings, these bio-engineered ingredients are now mainstream in sports nutrition, functional medical foods (FSMP), and premium veterinary formulas. This shift is powered by robust clinical evidence demonstrating how bioactive peptides promote recovery, enhance mobility, and support healthy metabolic function.
In North America and Europe, stringent regulatory bodies demand high levels of transparency, clinical proof, and pure source materials. Meanwhile, in rapidly developing regions across the Asia-Pacific, consumer awareness of healthy aging and gut health is fueling demand for clinical-grade collagen and plant-based protein supplements.
To address these trends, Hangzhou Fderla Biology Co., Ltd. maintains a diversified ingredient catalog. We offer marine-derived tripeptides for clean beauty and sports recovery, bovine-derived collagen for joint interventions, and plant-based proteins (such as soy and oat hydrolysates) to meet the growing demand for vegan alternatives.
Translating biological efficacy into targeted, real-world nutritional formulations.
Aging is linked to a gradual decline in digestive enzyme activity, leading to muscle loss (sarcopenia). By integrating our low-molecular-weight marine collagen peptides and plant-based isolates into daily diets, senior care facilities can help residents maintain optimal nitrogen retention and protect lean muscle mass without overloading their digestive systems.
Infants with cow's milk protein allergy (CMPA) require targeted nutrition. Our extensively hydrolyzed bovine whey and plant proteins ensure the removal of allergenic epitopes. This results in safe, easily digestible formulas that supply crucial amino acids for healthy cognitive and skeletal development.
Pet nutrition is adopting clinical-grade human standards. Our specialized hydrolyzed proteins, fortified with green-lipped mussel and cod cartilage, provide joint and gut lining support for senior dogs and cats, helping to soothe food sensitivities and improve overall mobility.
Global manufacturing demands a careful balance of raw material security, strict quality controls, and consistent pricing. Hangzhou Fderla Biology Co., Ltd. operates a modern production facility in Hangzhou, China, built to meet international GMP, ISO, and HACCP standards.
Our facility benefits from direct access to premium, sustainable raw material streams—ranging from deep-sea marine collagen sources to localized non-GMO soy and grain fields. This localized supply integration insulates our clients from the price volatility and sourcing disruptions common in the global market.
By combining advanced automation with multi-stage quality assurance protocols, we ensure that every batch of protein hydrolysate meets strict standards for purity, heavy-metal limits, microbial safety, and molecular weight distribution. Our centralized location near major logistics hubs allows us to manage reliable, cost-effective shipping networks for clients across North America, Europe, the Middle East, and Asia.
Ensuring compliance across diverse international markets and providing end-to-end documentation support.
Our ingredients are backed by a complete set of international certifications, including ISO 9001, ISO 22000, HACCP, HALAL, and KOSHER. This ensures smooth customs clearance and ready acceptance into diverse consumer markets.
We perform regular, independent third-party testing on all products. This guarantees strict compliance with global limits for heavy metals, pesticide residues, microbial counts, and chemical purity.
We work directly with your R&D teams to customize peptide profiles, adjust bulk densities, and optimize solubility. We also supply complete technical portfolios, including stability studies and efficacy documentation.
Browse our specialized ingredients designed for dietary supplements, functional foods, and advanced personal care formulations.
Hangzhou Fderla Biology Co., Ltd. is a professional hydrolyzed protein manufacturer and bioactive peptide supplier based in Hangzhou, China. The company focuses on the research, development, production, and global export of high-quality protein hydrolysates for food, cosmetic, and nutritional applications.
With advanced biotechnology processes and strict quality control systems, Fderla Biology produces a wide range of hydrolyzed protein ingredients, including plant-based, animal-based, and marine-derived protein peptides. These materials are widely used in functional foods, dietary supplements, skincare formulations, hair care products, and sports nutrition solutions.
The company integrates modern enzymatic hydrolysis technology with scientific formulation expertise to ensure high bioavailability, easy absorption, and stable performance of its protein products. Each batch is carefully tested to meet international standards for purity, safety, and effectiveness.
Hangzhou Fderla Biology Co., Ltd. supports OEM and customized solutions for global clients, including ingredient formulation optimization, technical support, and bulk supply services. With a strong focus on innovation and sustainable biotechnology, the company continuously develops new functional peptide solutions for emerging market needs.
By combining scientific research, production excellence, and global service capability, Fderla Biology has become a trusted partner in the hydrolyzed protein and bioactive peptide industry, delivering reliable and high-performance ingredient solutions worldwide.
Key technical and logistical information to help guide your sourcing and formulation decisions.
A transparent look inside our manufacturing processes, testing laboratories, and storage facilities.
Fderla Biology
